Skip to main content

Table 2 Left ventricle parameters of CMR in studied children of different sub-types of cardiomyopathy

From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool

Sub-types of cardiomyopathies LVEF% median (range) LVEDV (ml) median (range) LVEDVI median(range) LVESV (ml) median (range) LVESVI median (range)
Primary dilated 19.7 (12–54) b, c, d 208.8 (76–412) b, c, d 170.1 (89–338) a, b, c, d 162.9 (53–362) b, c, d 125.5 (41–257) b, c, d
Secondary dilated post myocarditis 29.5 (9–72) e 157 (121–367) e, f 82.6 (70–195) a, e 101.5 (42–327) e 56.7 (23–174) e
Secondary dilated toxins, drugs 43.8 (32–56) 43.4 (32–55) 41 (23–59) 22.8 (22–24) 20.7 (16–26)
Hypertrophic 65 (45–81) b, e 51 (16–172) b, e 75 (21–117) b, e 26.4 (6–59) b, e 26.3 (12–45) b, e
Non-compaction 60 (6–67) c 63 (6–135) c, f 66.3 (15–250) c 24 (3–127) c 56.7 (6–235) c
ARVD 42.3 (53–63) 68.3 (53–84) 73.8 (55–92) 30 (29–32) 32.3 (30–35)
Restrictive * * * * *
Infiltrative thalassemia 43.5 (21–66) d 113.8 (16–128) d 110.7 (18–119) d 66 (5–96) d 62.3 (6–94) d
Infiltrative others 70.2 (69–72) d 79.5 (26–134) d 63.6 (56–71) d 23 (8–38) d 18.9 (18–20) d
Ischemic 40.5 (35–46) 137.5 (19–256) 86.6 (41–132) 75.2 (12–138) 49 (27–71)
Test of significance 24.7 21.7 22.2 24.9 22.3
p value 0.006* 0.016* 0.014* 0.005* 0.013*
  1. Similar letters indicate significant difference